TIP608: Long-Term Compounding w/ Chris Mayer

Episode Summary

Executive Summary: Chris Mayer and Clay Fink discuss Mayer’s record 2023 fund performance and his long-term compounding philosophy, centered on owning high-quality, capital-efficient businesses and ignoring macro noise. The conversation dives deep into Constellation Software, Topicus, and Lumine—how they deploy capital, why spin-offs matter, how incentives are structured, and why valuation should be judged over 10-year horizons rather than quarter-to-quarter.

Main Topics: 2023 fund performance and compounding philosophy (Priority: 5/5): Mayer reviews his best annual return since launching the fund, highlighting zero sales, concentrated positions, and the importance of patience in high-quality compounders. Ignoring macro noise and focusing on business fundamentals (Priority: 5/5): He argues that recession forecasts, Fed narratives, and market headlines are often distractions; his process emphasizes long-term business quality, not daily price watching. Constellation Software as a capital-allocation machine (Priority: 5/5): The discussion covers Constellation’s accelerated acquisition pace, strong ROIC, organic growth, and ability to source attractive deals like Optimal Blue. Constellation 2.0 and the evolution of scale (Priority: 4/5): They examine how Constellation is reinventing itself through larger acquisitions and possible expansion beyond pure vertical market software. Spin-offs: Topicus and Lumine (Priority: 5/5): The episode explains why Constellation created public spin-offs, how incentives and geography/vertical specialization differ, and why they can create value for shareholders. Valuation and long-term return framing (Priority: 4/5): Mayer uses compounding math to show why paying seemingly high multiples can still be attractive if a business compounds at high rates for years.

Key Arguments: Long-term compounding beats macro speculation: Mayer says attention should go to what matters for a business over 10 years, not recession chatter or Fed predictions. Concentrated ownership with low turnover can work when the underlying businesses are exceptional; in 2023 he made only two major additions and sold nothing. Constellation’s recent outperformance reflects not just multiple expansion but a meaningful increase in capital deployment capacity and continued organic growth. The business model still has a large runway because the addressable market is vast, the company can buy very small niche software firms, and larger deals are now possible. Decentralization is powerful because decisions are made close to the problem, but it can create talent-retention and compensation challenges as the organization grows. Topicus and Lumine are useful experiments: Topicus tests higher-growth European software compounding, while Lumine emphasizes carve-outs and a narrower vertical. High headline multiples can be acceptable if the business can compound intrinsic value for a decade; the relevant question is total value creation, not the starting P/E alone. Spin-offs can surface opportunities because forced sellers and index/mandate constraints may create temporary price pressure after distribution.

Data Points: Fund return before fees (2023): 45% - Chris Mayer’s fund performance in 2023, described as his best annual return since launching the fund. Market return (2023): 24% - Used as a benchmark to show Mayer’s outperformance. Worst performer in Mayer’s portfolio (2023): up 19% - Heiko A was the weakest holding, yet still posted a strong gain. Lumine position return (2023): about 80% - One of Mayer’s biggest winners during the year. Technion position return (2023): about 80% - Another major winner in his concentrated portfolio. Copart return (2023): about 60% - A large portfolio holding that strongly contributed to performance. Constellation Software return (2023): about 60% - A major contributor to fund returns; Mayer views it as a high-quality compounder. Old Dominion return (2023): 43% - Illustrates that the stock rose despite revenue and EPS declines. Constellation IPO date: 2006 - Clay notes Constellation has been a 200-bagger since its IPO. Constellation cumulative return since IPO: 200-bagger - Shows the magnitude of long-term compounding in the business. Constellation ROIC: roughly 25% - Cited as the company’s historical return on invested capital. Constellation acquisitions deployed capital (2018-2020): $500M-$600M annually - Historical acquisition spending before the recent acceleration. Constellation acquisitions deployed capital (2021): about $1.5B - Shows the step-up in capital deployment. Constellation acquisitions deployed capital (2022): about $1.5B - Similar elevated pace to 2021. Constellation capital deployed through 3 quarters of 2023: over $2B - Indicates a further acceleration in acquisition volume. Optimal Blue purchase price: $700M - One of Constellation’s larger and more complex deals. Optimal Blue upfront cash paid: $200M - Constellation paid only a portion upfront. Optimal Blue seller note: $500M with no interest for five years - Shows favorable financing terms in the deal structure. Constellation small-deal valuation: around 1x sales - Clay and Chris discuss typical pricing for small VMS acquisitions. Private consolidators in VMS: 34 - Referenced from a report noting increased competition. Topicus organic growth: 6%-8% - Mayer says Topicus has historically grown organically faster than Constellation. Topicus maintenance/recurring growth: 8%-9% - A key reason Topicus compounds faster. Topicus third-quarter maintenance/recurring growth: 11% - A recent strong quarter cited in the discussion. Lumine organic growth (historical): 10% in 2021 - Used to explain why the business may justify a higher acquisition multiple. Topicus relative size: same size as Constellation in 2013 - Mayer uses this to argue Topicus still has a long runway. Topicus and Lumine market multiples discussed: 36x / 32x / 32x 2024 earnings - Approximate analyst-derived multiples shared for Constellation, Topicus, and Lumine. Typical CEO bonus reinvestment requirement: 75% - Used to explain alignment of management incentives at Constellation and spin-offs. CEO/shareholder lockup period: 3 to 5 years - Shares bought via bonus are locked up to align with long-term ownership. Topicus first trading price: around 17 - Lumine’s initial post-spin-off price context is contrasted with Topicus’s volatile path; Topicus later traded much higher before retracing. Lumine early trading turnover: more than 50% in first 10 days - Indicates heavy selling pressure after the spin-off. Topicus early trading turnover: about 15% in first 10 days - Much lower turnover than Lumine after spin-off. Lumine IPO/Spin-off end-of-year price: over 30 - Despite early weakness, the stock ended the year much higher. Cash in Mayer’s fund: less than 1% - Shows he was essentially fully invested at the time of the interview. Position size guardrail: 10% - Mayer prefers not to push positions above about 10% on new capital additions.

Pivotal Quotes: "The great secret of long-term investing in high, high-quality businesses is that the compounding is amazing." — Chris Mayer: He summarizes his investment philosophy while discussing why he holds winners for years and focuses on business quality. "I don't spend time on that macro sort of guesswork." — Chris Mayer: He explains why he ignores recession/Fed predictions and instead studies the businesses he owns. "If you really, if you love a company, you've done all the work... you can always build it up later." — Chris Mayer: His view on valuation and position sizing: start with conviction, then add over time if the business remains attractive.

Implications: For listeners, the episode reinforces that durable outperformance may come from owning a small number of exceptional businesses, staying patient through volatility, and evaluating opportunities on 5- to 10-year compounding power rather than short-term headlines.